[go: up one dir, main page]

HUP9700842A1 - Hatóanyagok szabályozott felszabadulását biztosító, stabilizált lipofil mátrixalapú gyógyászati készítmények - Google Patents

Hatóanyagok szabályozott felszabadulását biztosító, stabilizált lipofil mátrixalapú gyógyászati készítmények

Info

Publication number
HUP9700842A1
HUP9700842A1 HU9700842A HUP9700842A HUP9700842A1 HU P9700842 A1 HUP9700842 A1 HU P9700842A1 HU 9700842 A HU9700842 A HU 9700842A HU P9700842 A HUP9700842 A HU P9700842A HU P9700842 A1 HUP9700842 A1 HU P9700842A1
Authority
HU
Hungary
Prior art keywords
controlled release
stabilized
lipophyl
pharmaceutical compositions
active components
Prior art date
Application number
HU9700842A
Other languages
English (en)
Inventor
Gilles Fonknechten
Patrick Genty
Original Assignee
Adir Et Compagnie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir Et Compagnie filed Critical Adir Et Compagnie
Publication of HU9700842D0 publication Critical patent/HU9700842D0/hu
Publication of HUP9700842A1 publication Critical patent/HUP9700842A1/hu
Publication of HU222045B1 publication Critical patent/HU222045B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány új stabilizált lipőfil mátrixőkra vőnatkőzik, amelyekszabályőzőtt hatóanyag-felszabadűlást biztősító gyógyászati készít-mények előállítására alkalmazhatók. A fenti lipőfil mátrixők pőli-glikőzilezett vagy zsírsav-triglicerideket és stabilizátőrkéntcellűlóz-származékőt tartalmaznak. Ismertetik a fenti lipőfilmátrixők, valamint az azőkat tartalmazó gyógyászati készítményekelőállítását is. ŕ
HU9700842A 1996-05-06 1997-05-05 Hatóanyagok szabályozott felszabadulását biztosító, stabilizált lipofil mátrixalapú gyógyászati készítmények HU222045B1 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9605606A FR2748209B1 (fr) 1996-05-06 1996-05-06 Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs

Publications (3)

Publication Number Publication Date
HU9700842D0 HU9700842D0 (en) 1997-06-30
HUP9700842A1 true HUP9700842A1 (hu) 1998-08-28
HU222045B1 HU222045B1 (hu) 2003-04-28

Family

ID=9491845

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700842A HU222045B1 (hu) 1996-05-06 1997-05-05 Hatóanyagok szabályozott felszabadulását biztosító, stabilizált lipofil mátrixalapú gyógyászati készítmények

Country Status (16)

Country Link
EP (1) EP0806202B1 (hu)
JP (1) JP3983339B2 (hu)
CN (1) CN1171270A (hu)
AT (1) ATE212543T1 (hu)
AU (1) AU720146B2 (hu)
CA (1) CA2204475C (hu)
DE (1) DE69710121T2 (hu)
DK (1) DK0806202T3 (hu)
ES (1) ES2170922T3 (hu)
FR (1) FR2748209B1 (hu)
HU (1) HU222045B1 (hu)
NO (1) NO318227B1 (hu)
NZ (1) NZ314740A (hu)
PL (1) PL190562B1 (hu)
PT (1) PT806202E (hu)
ZA (1) ZA973836B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011363A3 (fr) * 1997-09-11 1999-08-03 Smb Technology Capsules semi-solides autoemulsionnables matricielles a action prolongee.
FR2782006B1 (fr) * 1998-08-07 2002-04-19 Gattefosse Ets Sa Composition a liberation prolongee apte a former une micro-emulsion
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
KR101152470B1 (ko) 2003-08-13 2012-06-01 바이오콘 리미티드 치료제용 마이크로-입자 지방산 염 고형 투약 제형
GB0324574D0 (en) * 2003-10-21 2003-11-26 Glaxo Group Ltd Novel compositions
US8333989B2 (en) 2005-10-26 2012-12-18 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
EP1951208A2 (en) * 2005-10-26 2008-08-06 Banner Pharmacaps Inc. Lipophilic vehicle-based dual controlled release matrix system as capsule fill
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
JP2013119540A (ja) * 2011-12-08 2013-06-17 Nipro Corp 固形医薬組成物およびその製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate

Also Published As

Publication number Publication date
CA2204475A1 (fr) 1997-11-06
HU222045B1 (hu) 2003-04-28
EP0806202A1 (fr) 1997-11-12
PL190562B1 (pl) 2005-12-30
AU720146B2 (en) 2000-05-25
DE69710121T2 (de) 2002-11-28
PT806202E (pt) 2002-06-28
CN1171270A (zh) 1998-01-28
ES2170922T3 (es) 2002-08-16
NO972068L (no) 1997-11-07
DK0806202T3 (da) 2002-05-06
PL319808A1 (en) 1997-11-10
ZA973836B (en) 1997-12-02
ATE212543T1 (de) 2002-02-15
FR2748209B1 (fr) 1998-06-05
FR2748209A1 (fr) 1997-11-07
NO972068D0 (no) 1997-05-05
HU9700842D0 (en) 1997-06-30
DE69710121D1 (de) 2002-03-14
NO318227B1 (no) 2005-02-21
JP3983339B2 (ja) 2007-09-26
JPH1045629A (ja) 1998-02-17
AU1999197A (en) 1997-11-13
EP0806202B1 (fr) 2002-01-30
CA2204475C (fr) 2002-12-03
NZ314740A (en) 1998-11-25

Similar Documents

Publication Publication Date Title
ES8608864A1 (es) Un procedimiento para producir un preparado a modo de hojas
CA2158630A1 (en) Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability
FR2559389B1 (fr) Procede pour la preparation de compositions pharmaceutiques a liberation soutenue, ayant une forte teneur en ingredient actif
IL56369A (en) Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
NO20005431D0 (no) Gelérbare farmasøytiske preparater
PT90764A (pt) Processo para a preparacaode um produto farmaceutico compreendendo um estrogenio e um anti-estrigenio e de composicoes farmaceuticas que os contem
GB1235787A (en) Sustained release pharmaceutical tablets
DE3579128D1 (de) 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
AU591185B2 (en) Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained
NO883229L (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
AU4846690A (en) Polyunsaturated fatty acid derivatives, pharmaceutical compositions containing the same, method for the preparation thereof, and their use as medicament
HUP9903855A2 (hu) Orális adagolásra való valproesavat tartalmazó gyógyszerészeti mikrogömbök
HUP9700842A1 (hu) Hatóanyagok szabályozott felszabadulását biztosító, stabilizált lipofil mátrixalapú gyógyászati készítmények
JPS542316A (en) Solid pharmaceutical composition containing nifedipene
ATE16394T1 (de) Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
ES544649A0 (es) Procedimiento para la preparacion de etofibrato o compuestossimilares que contienen microgranulos de liberacion constan-te
NO180473C (no) Fremgangsmåte for fremstilling av et enteralt, farmasöytisk fôrpreparat for behandling av ektoparasittiske fiskesykdommer
ES8302454A1 (es) "un metodo para preparar una composicion solida y estable a base de un farmaco facilmente oxidable al aire".
AR002972A1 (es) Pildoras que tienen una matriz farmaceutica que proporcionan un perfil apropiado de liberacion de la droga, composicion para la preparacion de dichamatriz, proceso para preparar dichas pildoras y formas de dosificacion de dicha composicion.
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
IL65922A0 (en) Preparation of apovincaminic acid esters,certain novel optically active derivatives thereof and pharmaceutical compositions containing them
OA08165A (fr) Nouveaux dérivés thiosulfonates, leur procédé de préparation ainsi que les compositions pharmaceutiques les contenant.
FI880210L (fi) Menetelmä valmistaa peroraalista stabiloitua, tehoainetta hidastetusti ja kontrolloidusti vapauttavaa, lääkevalmistetta
JPS5326316A (en) Drug containing active vitamin d3 derivatives and its preparation
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20030210

MM4A Lapse of definitive patent protection due to non-payment of fees